Bexxar, iodine I 131 tositumomab, effective in long-term follow-up of non-Hodgkin's lymphoma

Cancer Biol Ther. 2007 Jul;6(7):996-7.
No abstract available

Publication types

  • News
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Follow-Up Studies
  • Humans
  • Iodine Radioisotopes / therapeutic use*
  • Lymphoma, Non-Hodgkin / radiotherapy*
  • Radioimmunotherapy*

Substances

  • Antibodies, Monoclonal
  • Iodine Radioisotopes
  • tositumomab I-131